– The project “Nanodrone: Nanomedicines directed to Neuroblastoma” leaded by Dr. Alejandro Baeza has been one of the awardees of IDEA2 2015. The Madrid-MIT M+Visión Consortium, a partnership of the regional government of Madrid and the Massachusetts Institute of Technology (MIT) helps emerging innovators living and working in Madrid to refine their biomedical technology ideas and turn them into projects with higher potential for healthcare impact.
http://www.madrimasd.org/informacionidi/noticias/noticia.asp?id=65257
